Clinical Trial Update: Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update for loteprednol etabonate ophthalmic gel in treating ocular inflammation and pain after cataract surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Inflammation of the Eye
• Pain

Drugs mentioned

• Loteprednol etabonate ophthalmic gel (loteprednol etabonate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Inflammation, Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-09-03